Strategic Advice and Regulatory Analysis

BlueReg experienced consultants can provide insight into all regulatory requirements for France:

  • Drug Registration
  • Early Access Programmes
  • Post Marketing Authorisation Application (MAA) activities
  • Promotional material review
  • Quality systems and audits
  • Interactions with healthcare professionals includingcompliance with the French laws (DMOS, Transparence de liens, Charte de l’information promotionnelle)
  • Pharmacovigilance
  • Pricing and reimbursement

Our experts